Todd MCDERMOTT,Benjamin M. COLLMAN,Weili E. WANG,Peter T. MAYER,Albert SANTIAGO,Leana OKEEFFE,John B. MORRIS
申请号：
US15246279
公开号：
US20170189402A1
申请日:
2016.08.24
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention features solid dosage forms comprising two or more different active ingredients. In one embodiment, the present invention features a tablet dosage form comprising a first layer and a second layer, wherein the first layer comprises (1) 200 mg lopinavir, (2) ritonavir, (3) a pharmaceutically acceptable hydrophilic polymer, (4) a pharmaceutically acceptable surfactant, and (5) no more than 0.2% by weight of one or more lubricants, and the second layer comprises another therapeutic agent.
